tiprankstipranks
Advertisement
Advertisement

Ovid Therapeutics sees cash runway into late 2028

Cash, cash equivalents and marketable securities as of December 31, 2025 totaled $90.4 million.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1